Original Investigation

Inhaled Corticosteroids and Sickle Cell Disease Severity in Adults Without Asthma

JAMA Network Open 10.1001/jamanetworkopen.2026.42232

November 10, 2026 at 11:00 AM EST

Read the full article

In this trial of adults with SCD and ECW, extended courses of inhaled mometasone were associated with worsened markers of disease severity. Inhaled mometasone should not be used long-term in patients with SCD and ECW without a definitive diagnosis of asthma.

Corresponding Author: Susanna Curtis, MD, PhD, Division of Medicine, Icahn School of Medicine at Mount Sinai, 17 E 102nd St, New York, NY 10029 (susanna.curtis@mssm.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.42232

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks